News | Published:

Biased for benefit: Stimulating the world's most popular drug targets with more nuance

Nature Medicine volume 23, pages 649651 (2017) | Download Citation

  • A Correction to this article was published on 11 July 2017

This article has been updated

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Change history

  • 22 June 2017

    In the June 2017 issue, the story “Biased for benefit: Stimulating the world’s most popular drug targets with more nuance” (Nat. Med. 23, 649–651, 2017) misspelled the name of Laura Bohn’s postdoctoral advisor as Mark Caron. It should be spelled Marc Caron. The error has been corrected in the HTML and PDF versions of the article.

References

  1. 1.

    et al. Circ. Heart Fail. 5, 627–634 (2012).

  2. 2.

    et al. Circ. 135, e146–e603 (2017).

  3. 3.

    et al. J. Cardiol. Fail. 21, 27–43 (2015).

  4. 4.

    et al. Nat. Rev. Drug Discov. 16, 19–34 (2017).

  5. 5.

    et al. Proc. Nat. Acad. Sci. USA 103, 16284–16289 (2006).

  6. 6.

    et al. Basic Clin. Pharmacol. Toxicol. 100, 289–295 (2007).

  7. 7.

    et al. Am. J. Physiol. Heart. Circ. Physiol. 303, H1001–H1010 (2012).

  8. 8.

    et al. Science 283, 655–661 (1999).

  9. 9.

    et al. Eur. Heart J. 10.1093/eurheartj/ehx196 (2017).

  10. 10.

    et al. Br. J. Pharmacol. 167, 960–969 (2012).

  11. 11.

    et al. J. Pharmacol. Exp. Ther. 342, 799–807 (2012).

  12. 12.

    et al. Science 286, 2495–2498 (1999).

  13. 13.

    et al. J. Pharmacol. Exp. Ther. 314, 1195–1201 (2005).

  14. 14.

    et al. MMWR Morb. Mortal. Wkly Rep. 65, 1445–1452 (2016).

  15. 15.

    et al. Nature 537, 185–190 (2016).

Download references

Author information

Affiliations

  1. Dyani Lewis is a freelance science journalist based in Hobart, Australia.

    • Dyani Lewis

Authors

  1. Search for Dyani Lewis in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nm0617-649

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing